))
Should We Be Rethinking the Scientific Publication?
Manage episode 377679332 series 3310882
Content provided by Danish Diabetes and Endocrine Academy, Danish Diabetes, and Endocrine Academy. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Danish Diabetes and Endocrine Academy, Danish Diabetes, and Endocrine Academy or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Is the scientific publication, as we know it, dead?
This was the central question behind the theme for this year’s DDEA Postdoc Summit Challenge.
Researchers learn early on to think in terms of impact factors and citation metrics. In an overflowing ocean of scientific content, the pressure to make your publications matter seems higher than ever. Yet according to recent studies, the impact of Danish research has been on an overall steady decline, and papers are generally becoming less disruptive over time.
But what is scientific impact and how is it measured? And is it time to look at alternatives to a practice that has changed very little in the last 100 years?
In this episode, we hand over the microphone to a postdoc, Christopher Lewis, who landed an interview with none other than the Senior Vice President of Impact at the Novo Nordisk Foundation, Thomas Alslev Christensen.
Listen, as an early-career researcher addresses the burning questions about the direction of scientific impact to one with a job specifically tied to this subject at a highly influential research institution.
The Novo Nordisk Foundation:
The Novo Nordisk Foundation (NNF) is a Danish foundation supporting the business and research activities of the Novo Group’s companies (Novo Nordisk A/S and Novozymes A/S), providing support for scientific, humanitarian, and social purposes. In 2022, the NNF granted DKK 7.464 billion DKK for a total of 695 new initiatives. The DDEA is funded by the NNF with a five-year grant of 194 million DKK.
Guests
- Thomas Alslev Christensen, Senior Vice President of Impact at the Novo Nordisk Foundation
Host
- Christopher Lewis, Postdoc, University of Copenhagen
Produced by
Gretchen Repasky, Education & Networking Manager, Danish Diabetes and Endocrine Academy
Published by
Danish Diabetes and Endocrine Academy
Editor
Nikolai Rosler – Rosler Productions
You can find additional information about our podcasts on Podcasts | Danish Diabetes and Endocrine Academy (ddeacademy.dk)
19 episodes
Share
